John P. Longenecker

Fondateur chez Jpl Biotech

Profil

John P.
Longenecker founded Jpl Biotech, where he worked as President.
Dr. Longenecker also currently works at HBM Healthcare Investments (Cayman) Ltd., as Director.
Dr. Longenecker also formerly worked at Favrille, Inc., as President, Chief Executive Officer & Director from 2002 to 2009, Aileron Therapeutics, Inc., as President & Chief Executive Officer in 2018, VitreoRetinal Technologies, Inc., as President, Chief Executive Officer & Director from 2009 to 2010, HemaQuest Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2010 to 2014, MMRGlobal, Inc., as President & Chief Executive Officer, Scios, Inc., as Vice President & Development Director from 1982 to 1992, Karo Healthcare AB, as Director, Pacira Biosciences, Inc., as Independent Director, Karo Bio USA, Inc., as Director, Meta Bio, as Director, DepoTech Corp., as President & Chief Operating Officer from 1998 to 1999, SkyePharma Plc, as President from 1999 to 2002, and Pacira Pharmaceuticals, Inc. (California), as President-US Operations.
Dr. Longenecker received his doctorate degree in 1980 from Australian National University and undergraduate degree in 1969 from Purdue University.

Postes actifs de John P. Longenecker

Sociétés	Poste	Début
Jpl Biotech	Fondateur	-
HBM Healthcare Investments (Cayman) Ltd.	Directeur/Membre du Conseil	-

Anciens postes connus de John P. Longenecker

Sociétés	Poste	Fin
REIN THERAPEUTICS INC.	Directeur Général	06/09/2018
HemaQuest Pharmaceuticals, Inc.	Directeur Général	01/05/2014
VitreoRetinal Technologies, Inc.	President	01/03/2010
Favrille, Inc.	Directeur Général	01/01/2009
SKYEPHARMA PLC	President	01/02/2002